Last Updated:
Name Designation Appointment Date Status
Umang Rajkumar Budhraja

Appointed as Director since January 2024

Director 03-Jan-2024 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Nidhi Umang Budhraja

Appointed as Director since January 2024

Director 03-Jan-2024 Current

People Timeline

Explore the timeline of key personnel in Excipient Granules And Ingredients Private Limited's leadership journey.

Loading...
Contact Details
  • Address Flt No 410 Bldg No 21, Samarth Angan-Ib, Millat, Mumbai Maharashtra, 400053, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400053
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Excipient Granules And Ingredients Private Limited?
You can contact Excipient Granules And Ingredients Private Limited through their registered address at Flt No 410 Bldg No 21, Samarth Angan-Ib, Millat, Mumbai Maharashtra, 400053, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Excipient Granules And Ingredients Private Limited?
The current directors of Excipient Granules And Ingredients Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • NIDHI UMANG BUDHRAJA
  • UMANG RAJKUMAR BUDHRAJA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available